eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | intestinal disease |
| Comorbidity | C0011303|demyelinating disease |
| Sentences | 1 |
| PubMedID- 25348720 | Conclusion: anti-tnfalpha biologics do not appear to impact the risk of developing clinical idiopathic inflammatory demyelinating disease in patients with inflammatory bowel disease. |
Page: 1